WebNov 11, 2016 · Aims. As patients with heart failure (HF) and concomitant diabetes carry a poor prognosis, this post-hoc subgroup analysis aimed to compare the outcomes of patients with and without diabetes randomized in the Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT) study.. Methods and results. EchoCRT … WebFeb 16, 2010 · As the largest, prospective, randomized, double-blind, international, multicenter clinical trial of its kind, the landmark EchoCRT study will randomize more …
BIOTRONIK: EchoCRT, the Largest Trial of Its Kind, Enrolls First ...
WebAug 26, 2008 · “ The EchoCRT study has been designed under guidance from an executive steering committee of 11 internationally-renowned academic specialists in … WebFeb 16, 2010 · The first device within the EchoCRT study was implanted in 2008 in Ohio, USA. All patients are implanted with the BIOTRONIK Lumax HF-T CRT-D device with BIOTRONIK Home Monitoring®. The Home Monitoring data will be used in a pre-specified analysis to evaluate the frequency and duration of irregular heart rhythms. Patients will … c 車 ランプ
CRT Does Not Benefit Patients with Narrow QRS and …
WebAug 28, 2024 · A second look at data from the halted EchoCRT trial has identified a subgroup of heart failure patients with QRS duration less than 130 ms who may benefit from CRT. Details were just presented at the … WebSep 3, 2013 · EchoCRT is the largest investigator-initiated, international, multi-centre, prospective, randomized, double-blind, clinical trial of its kind. At study closure, there were 809 patients randomized to CRT=ON or CRT=OFF and followed for a mean of 19.6 months. WebSep 4, 2008 · The EchoCRT study will randomize patients with heart failure, already receiving current standard pharmacological therapy, with a narrow QRS width (less than … c軸とは